122 related articles for article (PubMed ID: 33035538)
21. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
[TBL] [Abstract][Full Text] [Related]
22. Transdermal finasteride delivery via powder-carrying microneedles with a diffusion enhancer to treat androgenetic alopecia.
Kim S; Eum J; Yang H; Jung H
J Control Release; 2019 Dec; 316():1-11. PubMed ID: 31689460
[TBL] [Abstract][Full Text] [Related]
23. Dermal toxicity of topical (-)epigallocatechin-3-gallate in BALB/c and SKH1 mice.
Stratton SP; Bangert JL; Alberts DS; Dorr RT
Cancer Lett; 2000 Sep; 158(1):47-52. PubMed ID: 10940508
[TBL] [Abstract][Full Text] [Related]
24. Position and orientation of gallated proanthocyanidins in lipid bilayer membranes: influence of polymerization degree and linkage type.
Zhu W; Khalifa I; Peng J; Li C
J Biomol Struct Dyn; 2018 Aug; 36(11):2862-2875. PubMed ID: 28844180
[TBL] [Abstract][Full Text] [Related]
25. Skin penetration of epigallocatechin-3-gallate and quercetin from green tea and Ginkgo biloba extracts vehiculated in cosmetic formulations.
dal Belo SE; Gaspar LR; Maia Campos PM; Marty JP
Skin Pharmacol Physiol; 2009; 22(6):299-304. PubMed ID: 19786823
[TBL] [Abstract][Full Text] [Related]
26. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
[TBL] [Abstract][Full Text] [Related]
27. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
28. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies.
Isbrucker RA; Edwards JA; Wolz E; Davidovich A; Bausch J
Food Chem Toxicol; 2006 May; 44(5):636-50. PubMed ID: 16387402
[TBL] [Abstract][Full Text] [Related]
29. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
Singh M; Bhatnagar P; Mishra S; Kumar P; Shukla Y; Gupta KC
Int J Nanomedicine; 2015; 10():6789-809. PubMed ID: 26586942
[TBL] [Abstract][Full Text] [Related]
30. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.
Fangueiro JF; Calpena AC; Clares B; Andreani T; Egea MA; Veiga FJ; Garcia ML; Silva AM; Souto EB
Int J Pharm; 2016 Apr; 502(1-2):161-9. PubMed ID: 26921515
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives.
Zhang X; Wang J; Hu JM; Huang YW; Wu XY; Zi CT; Wang XJ; Sheng J
Molecules; 2016 May; 21(5):. PubMed ID: 27187321
[TBL] [Abstract][Full Text] [Related]
32. Tannic acid as a co-former in co-amorphous systems: Enhancing their physical stability, solubility and dissolution behavior.
Fael H; Demirel AL
Int J Pharm; 2020 May; 581():119284. PubMed ID: 32243965
[TBL] [Abstract][Full Text] [Related]
33. Hyaluronic Acid/PLGA Core/Shell Fiber Matrices Loaded with EGCG Beneficial to Diabetic Wound Healing.
Shin YC; Shin DM; Lee EJ; Lee JH; Kim JE; Song SH; Hwang DY; Lee JJ; Kim B; Lim D; Hyon SH; Lim YJ; Han DW
Adv Healthc Mater; 2016 Dec; 5(23):3035-3045. PubMed ID: 27805803
[TBL] [Abstract][Full Text] [Related]
34. Promotion of full-thickness wound healing using epigallocatechin-3-O-gallate/poly (lactic-co-glycolic acid) membrane as temporary wound dressing.
Kim HL; Lee JH; Kwon BJ; Lee MH; Han DW; Hyon SH; Park JC
Artif Organs; 2014 May; 38(5):411-7. PubMed ID: 24571533
[TBL] [Abstract][Full Text] [Related]
35. A Double-Blind, Randomized Trial Shows the Role of Zonal Priming and Direct Topical Application of Epigallocatechin-3-Gallate in the Modulation of Cutaneous Scarring in Human Skin.
Ud-Din S; Foden P; Mazhari M; Al-Habba S; Baguneid M; Bulfone-Paus S; McGeorge D; Bayat A
J Invest Dermatol; 2019 Aug; 139(8):1680-1690.e16. PubMed ID: 30822414
[TBL] [Abstract][Full Text] [Related]
36. Epigallocatechin-3-O-Gallate-Loaded Poly(lactic-co-glycolic acid) Fibrous Sheets as Anti-Adhesion Barriers.
Lee JH; Shin YC; Yang WJ; Park JC; Hyon SH; Han DW
J Biomed Nanotechnol; 2015 Aug; 11(8):1461-71. PubMed ID: 26295146
[TBL] [Abstract][Full Text] [Related]
37. Ethosomal (-)-epigallocatechin-3-gallate as a novel approach to enhance antioxidant, anti-collagenase and anti-elastase effects.
Yücel Ç; Şeker Karatoprak G; Yalçıntaş S; Eren Böncü T
Beilstein J Nanotechnol; 2022; 13():491-502. PubMed ID: 35707628
[TBL] [Abstract][Full Text] [Related]
38. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.
Frias I; Neves AR; Pinheiro M; Reis S
Drug Des Devel Ther; 2016; 10():3519-3528. PubMed ID: 27826184
[TBL] [Abstract][Full Text] [Related]
39. Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications.
Chen J; Wei N; Lopez-Garcia M; Ambrose D; Lee J; Annelin C; Peterson T
Eur J Pharm Biopharm; 2017 Aug; 117():286-291. PubMed ID: 28411056
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the Effect of Different Emulsifiers on the Transdermal Delivery of EGCG Entrapped in a Polymeric Micelle System.
Casiraghi A; Franzè S; Selmin F; Dazio V; Minghetti P
Planta Med; 2017 Mar; 83(5):405-411. PubMed ID: 27286328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
